Redbiotec announces today the appointment of Dr. Sallie Permar, MD PhD, Associate Professor of Pediatrics at Duke University School of Medicine, to Redbiotec’s Scientific Advisory Board.
Dr. Permar is a leading scientist studying neonatal viral pathogenesis including congenital Cytomegalovirus (CMV) infection. Dr. Permar and her team utilize nonhuman primate models and human cohort studies to understand and elicit immune responses that can prevent vertical virus transmission.
Redbiotec’s team has the goal to develop the first CMV vaccine on the market and we are glad that Dr. Permar will scientifically support Redbiotec in its efforts.